MTOR and acute lymphoblastic leukemia: Treatment with dual PI3K/mTOR inhibitors or mTOR kinase inhibitors alone or in combination with conventional ALL therapies or targeted drugs for different cellular cascades can block distinct mechanisms of cell survival in ALL and inhibit cell proliferation and induces apoptosis [25,29,32].